These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6384253)

  • 21. Normalisation of gonadotropin release by pump assisted pulsatile gonadotropin releasing hormone (GnRH) replacement in hypogonadotropic men.
    Hetzel WD; Sir-Petermann T; Siebling U; Pfeiffer EF
    Life Support Syst; 1985; 3 Suppl 1():556-60. PubMed ID: 3939676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of ovulation and fertility in amenorrheic women by pulsatile low-dose gonadotropin-releasing hormone.
    Hurley DM; Brian R; Outch K; Stockdale J; Fry A; Hackman C; Clarke I; Burger HG
    N Engl J Med; 1984 Apr; 310(17):1069-74. PubMed ID: 6424012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
    Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotrophin-releasing hormone release into the hypophyseal portal blood of the ewe mirrors both pulsatile and continuous intravenous infusion of kisspeptin: an insight into kisspeptin's mechanism of action.
    Caraty A; Lomet D; Sébert ME; Guillaume D; Beltramo M; Evans NP
    J Neuroendocrinol; 2013 Jun; 25(6):537-46. PubMed ID: 23387514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) pulse pattern regulates GnRH receptor gene expression: augmentation by estradiol.
    Yasin M; Dalkin AC; Haisenleder DJ; Kerrigan JR; Marshall JC
    Endocrinology; 1995 Apr; 136(4):1559-64. PubMed ID: 7895666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsatile administration of GnRH for the treatment of hypogonadotrophic hypogonadism.
    Menon V; Butt WR; Clayton RN; Edwards RL; Lynch SS
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):223-32. PubMed ID: 6383664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone.
    Porchet HC; Le Cotonnec JY; Neuteboom B; Canali S; Zanolo G
    J Clin Endocrinol Metab; 1995 Feb; 80(2):667-73. PubMed ID: 7852534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose pulsatile gonadotropin-releasing hormone in anorexia nervosa: a model of human pubertal development.
    Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1979 Nov; 49(5):712-8. PubMed ID: 385613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man.
    Veldhuis JD; Borges JL; Drake CR; Rogol AD; Kaiser DL; Thorner MO
    J Clin Endocrinol Metab; 1985 Jan; 60(1):144-9. PubMed ID: 3880562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin-releasing hormone infusion interval: importance in pharmacodynamics.
    Schmutzler R; Elkind-Hirsch K; Hahn D; McGuire JL; Simon JA; Danforth DR; Hodgen GD
    J Med Primatol; 1989; 18(5):373-82. PubMed ID: 2681784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor: pharmacokinetics in man.
    Schulte HM; Chrousos GP; Booth JD; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1984 Jan; 58(1):192-6. PubMed ID: 6605972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of gonadotropin secretion in the ovine fetus: the effects of a specific gonadotropin-releasing hormone antagonist on pulsatile luteinizing hormone secretion.
    Matwijiw I; Faiman C
    Endocrinology; 1987 Jul; 121(1):347-51. PubMed ID: 3297644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.